In silico identification and evaluation of leads for the simultaneous inhibition of protease and helicase activities of HCV NS3/4A protease using complex based pharmacophore mapping and virtual screening.
Hepatitis C virus (HCV) infection is an alarming and growing threat to public health. The present treatment gives limited efficacy and is poorly tolerated, recommending the urgent medical demand for novel therapeutics. NS3/4A protease is a significant emerging target for the treatment of HCV infecti...
Main Authors: | Abdul Wadood, Muhammad Riaz, Reaz Uddin, Zaheer Ul-Haq |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3923879?pdf=render |
Similar Items
-
A Novel Approach to Develop New and Potent Inhibitors for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease: A Computational Approach
by: Muhammad Riaz, et al.
Published: (2023-01-01) -
Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection
by: Nikhil Pathak, et al.
Published: (2017-12-01) -
Targeting Dengue Virus NS-3 Helicase by Ligand based Pharmacophore Modeling and Structure based Virtual Screening
by: Sobia A. Halim, et al.
Published: (2017-10-01) -
Functional interplay among the flavivirus NS3 protease, helicase, and cofactors
by: Li, Kuohan, et al.
Published: (2014) -
The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development
by: Luo, Dahai, et al.
Published: (2016)